Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
LGG-47. VINBLASTINE TO PREVENT TUMOUR REBOUND AFTER BEVAC... | ResearchHub
Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
LGG-47. VINBLASTINE TO PREVENT TUMOUR REBOUND AFTER BEVACIZUMAB/IRINOTECAN IN CHILDREN AND ADOLESCENTS WITH MULTIPLY RELAPSED LOW-GRADE GLIOMAS: THE SOUTH LONDON PAEDIATRIC & TYA NEURO-ONCOLOGY NETWORK EXPERIENCE
0
Authors
Annette Weiser
8 more
Annette Weiser
•
Julia Cockle
6 more
•
Fernando Carceller
Published
June 18, 2024
Paper
Conversation
0
Reviews
0
Bounties
0
Sign in to review
Share your thoughts on this paper...
Best
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
Neuro-Oncology
Topics
Medicine
Cancer Oncology
Internal Medicine
Pediatrics
Neurology
Show all topics
DOI
10.1093/neuonc/noae064.438
License
CC-BY-NC
Other Formats
PDF
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
Neuro-Oncology
Topics
Medicine
Cancer Oncology
Internal Medicine
Pediatrics
Neurology
Show all topics
DOI
10.1093/neuonc/noae064.438
License
CC-BY-NC
Other Formats
PDF
